Baseline characteristics
| Characteristic . | SNUH, n (%) . | KCCR, n (%) . |
|---|---|---|
| Total patients | 131 | 1933 |
| Median (range) age, y | 59 (20-89) | 58 (20-91) |
| Male sex | 82 (62.6) | 1194 (61.8) |
| CCI, points | ||
| 1-3 | 120 (91.6) | 1719 (88.9) |
| ≥4 | 11 (8.4) | 214 (11.1) |
| Pathologic subtype | ||
| PTCL-NOS | 46 (35.1) | 1075 (55.6) |
| AITL | 48 (36.6) | 445 (23.0) |
| ALCL | 27 (20.6) | 326 (16.9) |
| EATL | 7 (5.3) | 40 (2.1) |
| SPTCL | 3 (2.3) | 38 (2.0) |
| HSTCL | 0 | 9 (0.5) |
| Stage | ||
| 1-2 | 26 (19.8) | 511 (26.3) |
| 3-4 | 105 (80.2) | 674 (34.7) |
| Unknown | 0 | 748 (38.7) |
| First-line chemotherapy group | ||
| 1 | 106 (80.9) | 748 (38.7) |
| 2 | 23 (17.6) | 678 (35.1) |
| 3 | 2 (1.5) | 113 (5.9) |
| 4 | 0 | 394 (20.3) |
| HSCT | ||
| Yes | 22 (16.8) | 273 (11.6) |
| Autologous HSCT | 21 (95.5) | 171 (62.6) |
| Upfront | 8 (38.0) | NA |
| Salvage | 13 (61.9) | NA |
| Allogeneic HSCT | 1 (4.5) | 22 (8.1) |
| Upfront | 0 | NA |
| Salvage | 1 (100) | NA |
| Cord | 0 | 80 (29.3) |
| No | 109 (83.2) | 1660 (85.9) |
| Characteristic . | SNUH, n (%) . | KCCR, n (%) . |
|---|---|---|
| Total patients | 131 | 1933 |
| Median (range) age, y | 59 (20-89) | 58 (20-91) |
| Male sex | 82 (62.6) | 1194 (61.8) |
| CCI, points | ||
| 1-3 | 120 (91.6) | 1719 (88.9) |
| ≥4 | 11 (8.4) | 214 (11.1) |
| Pathologic subtype | ||
| PTCL-NOS | 46 (35.1) | 1075 (55.6) |
| AITL | 48 (36.6) | 445 (23.0) |
| ALCL | 27 (20.6) | 326 (16.9) |
| EATL | 7 (5.3) | 40 (2.1) |
| SPTCL | 3 (2.3) | 38 (2.0) |
| HSTCL | 0 | 9 (0.5) |
| Stage | ||
| 1-2 | 26 (19.8) | 511 (26.3) |
| 3-4 | 105 (80.2) | 674 (34.7) |
| Unknown | 0 | 748 (38.7) |
| First-line chemotherapy group | ||
| 1 | 106 (80.9) | 748 (38.7) |
| 2 | 23 (17.6) | 678 (35.1) |
| 3 | 2 (1.5) | 113 (5.9) |
| 4 | 0 | 394 (20.3) |
| HSCT | ||
| Yes | 22 (16.8) | 273 (11.6) |
| Autologous HSCT | 21 (95.5) | 171 (62.6) |
| Upfront | 8 (38.0) | NA |
| Salvage | 13 (61.9) | NA |
| Allogeneic HSCT | 1 (4.5) | 22 (8.1) |
| Upfront | 0 | NA |
| Salvage | 1 (100) | NA |
| Cord | 0 | 80 (29.3) |
| No | 109 (83.2) | 1660 (85.9) |
HSCT, hematopoietic stem-cell transplantation; HSTCL, hepatosplenic T-cell lymphoma; NA, not available; SNUH, Seoul National University Hospital.